These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2431192)

  • 1. Stainable aluminum and not aluminum content reflects bone histology in dialyzed patients.
    Faugere MC; Malluche HH
    Kidney Int; 1986 Nov; 30(5):717-22. PubMed ID: 2431192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can bone histomorphometry be predicted by clinical assessment and noninvasive techniques in peritoneal dialysis?
    Joffe P; Heaf JG; Jensen C
    Miner Electrolyte Metab; 1996; 22(4):224-33. PubMed ID: 8807626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of bone aluminum content and bone histology in patients on chronic hemodialysis and hemofiltration.
    Sebert JL; Fournier A; Leflon P; Fohrer P; de Frémont JF; Morinière P; Galy C; Marie A; Demontis R; Boudailliez B
    Nephron; 1986; 42(1):34-40. PubMed ID: 3941748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal osteodystrophy in predialysis patients without stainable bone aluminum. A cross-sectional bone-histomorphometric study.
    Dahl E; Nordal KP; Attramadal A; Halse J; Flatmark A
    Acta Med Scand; 1988; 224(2):157-64. PubMed ID: 2458677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adynamic bone disease with negative aluminium staining in predialysis patients: prevalence and evolution after maintenance dialysis.
    Hernandez D; Concepcion MT; Lorenzo V; Martinez ME; Rodriguez A; De Bonis E; Gonzalez-Posada JM; Felsenfeld AJ; Rodriguez M; Torres A
    Nephrol Dial Transplant; 1994; 9(5):517-23. PubMed ID: 7522307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a toxic effect of aluminum on osteoblasts: a histomorphometric study in hemodialysis patients with aplastic bone disease.
    Parisien M; Charhon SA; Arlot M; Mainetti E; Chavassieux P; Chapuy MC; Meunier PJ
    J Bone Miner Res; 1988 Jun; 3(3):259-67. PubMed ID: 3213621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aluminum-associated bone disease in chronic renal failure: high prevalence in a long-term dialysis population.
    Andress DL; Maloney NA; Endres DB; Sherrard DJ
    J Bone Miner Res; 1986 Oct; 1(5):391-8. PubMed ID: 3503554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlations between bone histopathology and serum biochemistry in uremic patients on chronic hemodialysis.
    Canavese C; Barolo S; Gurioli L; Cadario A; Portigliatti M; Isaia G; Thea A; Marangella M; Bongiorno P; Cavagnino A; Peona C; Boero R; D'Amicone M; Cardelli R; Rossi P; Piccoli G
    Int J Artif Organs; 1998 Aug; 21(8):443-50. PubMed ID: 9803345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone histologic response to deferoxamine in aluminum-related bone disease.
    Andress DL; Nebeker HG; Ott SM; Endres DB; Alfrey AC; Slatopolsky EA; Coburn JW; Sherrard DJ
    Kidney Int; 1987 Jun; 31(6):1344-50. PubMed ID: 2441107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone aluminum accumulation in hemodialysis patients: a longitudinal perspective.
    Kopp JB; Andress DL; Maloney NA; Sherrard DJ
    Am J Kidney Dis; 1988 Sep; 12(3):214-9. PubMed ID: 3414677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deferoxamine-induced bone changes in haemodialysis patients: a histomorphometric study.
    Charhon SA; Chavassieux P; Boivin G; Parisien M; Chapuy MC; Traeger J; Meunier PJ
    Clin Sci (Lond); 1987 Aug; 73(2):227-34. PubMed ID: 3652627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone histomorphometry in renal osteodystrophy.
    Ott SM
    Semin Nephrol; 2009 Mar; 29(2):122-32. PubMed ID: 19371803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histomorphometric evidence of deleterious effect of aluminum on osteoblasts.
    de Vernejoul MC; Belenguer R; Halkidou H; Buisine A; Bielakoff J; Miravet L
    Bone; 1985; 6(1):15-20. PubMed ID: 2581595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aluminum-related bone disease in mild and advanced renal failure: evidence for high prevalence and morbidity and studies on etiology and diagnosis.
    Smith AJ; Faugère MC; Abreo K; Fanti P; Julian B; Malluche HH
    Am J Nephrol; 1986; 6(4):275-83. PubMed ID: 3777036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A pathological analysis of 51 cases of renal osteodystrophy].
    Yu YF; Hu YX; Zhu P
    Zhonghua Nei Ke Za Zhi; 1993 Jul; 32(7):448-50. PubMed ID: 8275821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogenesis of renal osteodystrophy: role of vitamin D, aluminium, parathyroid hormone, calcium and phosphorus.
    Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Johnson JR; George CR; Collett P; Kalowski S
    Q J Med; 1985 May; 55(217):127-44. PubMed ID: 4001311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aluminum and parathyroid hormone on osteoblasts and bone mineralization in chronic renal failure.
    Dunstan CR; Evans RA; Hills E; Wong SY; Alfrey AC
    Calcif Tissue Int; 1984 Mar; 36(2):133-8. PubMed ID: 6430496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum aluminum levels as a reflection of renal osteodystrophy status and bone surface aluminum staining.
    Hodsman AB; Steer BM
    J Am Soc Nephrol; 1992 Feb; 2(8):1318-27. PubMed ID: 1378308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fluoride on aluminum-induced bone disease in rats with renal failure.
    Ittel TH; Gruber E; Heinrichs A; Handt S; Hofstädter F; Sieberth HG
    Kidney Int; 1992 May; 41(5):1340-8. PubMed ID: 1614048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aluminum associated bone disease: clinico-pathologic correlation.
    Ihle B; Buchanan M; Stevens B; Marshal A; Plomley R; d'Apice A; Kincaid-Smith P
    Am J Kidney Dis; 1982 Sep; 2(2):255-63. PubMed ID: 7124722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.